Pui Wang

Lika, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Glucagon-like peptide-1 receptor agonist prevents pulmonary fibrosis following acute COVID-19 infection associated with type 2 diabetes.

Glucagon-like peptide-1 receptor agonist prevents pulmonary fibrosis following acute COVID-19 infection associated with type 2 diabetes.

Journal: Journal of virology

Published: July 09, 2026

Sialic acid-anchored haemagglutinin stalk neutralizing antibody M-SiaB enhances protection against highly pathogenic influenza H5N1/Texas/2024.

Sialic acid-anchored haemagglutinin stalk neutralizing antibody M-SiaB enhances protection against highly pathogenic influenza H5N1/Texas/2024.

Journal: Nature communications

Published: March 21, 2026

Cattle and human organoids reveal 2.3.4.4b H5N1 cross-species transmission potential and neuraminidase-specific neutralizing antibodies in humans.

Cattle and human organoids reveal 2.3.4.4b H5N1 cross-species transmission potential and neuraminidase-specific neutralizing antibodies in humans.

Journal: Nature communications

Published: January 06, 2026

Influenza NS1 drives N6-methyladenosine (m6A)-mediated autoregulation of viral mRNA splicing.

Influenza NS1 drives N6-methyladenosine (m6A)-mediated autoregulation of viral mRNA splicing.

Journal: Emerging microbes & infections

Published: October 09, 2025

Avian Influenza Virus A(H5N1) Genotype D1.1 Is Better Adapted to Human Nasal and Airway Organoids Than Genotype B3.13.

Avian Influenza Virus A(H5N1) Genotype D1.1 Is Better Adapted to Human Nasal and Airway Organoids Than Genotype B3.13.

Journal: The Journal of infectious diseases

Published: May 23, 2025

Epstein-Barr Virus Expressed Long Non-Coding RNA (lncBARTs) Regulate EBV Latent Genome Replication.

Epstein-Barr Virus Expressed Long Non-Coding RNA (lncBARTs) Regulate EBV Latent Genome Replication.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: April 23, 2025

Risk assessment of 2024 cattle H5N1 using age-stratified serosurveillance data.

Risk assessment of 2024 cattle H5N1 using age-stratified serosurveillance data.

Journal: Emerging microbes & infections

Published: April 22, 2025

Intranasal influenza virus-vectored vaccine offers protection against clade 2.3.4.4b H5N1 infection in small animal models.

Intranasal influenza virus-vectored vaccine offers protection against clade 2.3.4.4b H5N1 infection in small animal models.

Journal: Nature communications

Published: August 22, 2024

A Prime-Boost Vaccination Approach Induces Lung Resident Memory CD8+ T Cells Derived from Central Memory T Cells That Prevent Tumor Lung Metastasis.

A Prime-Boost Vaccination Approach Induces Lung Resident Memory CD8+ T Cells Derived from Central Memory T Cells That Prevent Tumor Lung Metastasis.

Journal: Cancer research

Published: October 25, 2023

Argonaute 2 inhibits RIG-I signaling via competition for viral RNA binding.

Argonaute 2 inhibits RIG-I signaling via competition for viral RNA binding.

Journal: iScience

Published: August 23, 2023

Multi-omics analysis of attenuated variant reveals potential evaluation marker of host damaging for SARS-CoV-2 variants.

Multi-omics analysis of attenuated variant reveals potential evaluation marker of host damaging for SARS-CoV-2 variants.

Journal: Science China. Life sciences

Published: April 17, 2023

A Phase 1, Randomized, Double-Blinded, Placebo-Controlled and Dose-Escalation Study to Evaluate the Safety and Immunogenicity of the Intranasal DelNS1-nCoV-RBD LAIV for COVID-19 in Healthy Adults.

A Phase 1, Randomized, Double-Blinded, Placebo-Controlled and Dose-Escalation Study to Evaluate the Safety and Immunogenicity of the Intranasal DelNS1-nCoV-RBD LAIV for COVID-19 in Healthy Adults.

Journal: Vaccines

Published: February 03, 2023

Showing 1-12 of 34

Last Updated: 09/26/2026